Myriad Genetics (MYGN) PT Raised to $22 at Jefferies
Tweet Send to a Friend
Jefferies analyst Brandon Couillard raised the price target on Myriad Genetics (NASDAQ: MYGN) to $22.00 (from $20.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
